|
|
||||
|
Few attend BioShield II hearing
Email: Alicia Ault - afault@yahoo.com News from The Scientist 2004, 5(1):20041007-01
|
||||
|
|
||||
|
WASHINGTON, DC—At a sparsely attended Senate hearing Wednesday (October 6) on potential improvements to the BioShield legislation signed into law in July, several pharmaceutical manufacturers pleaded for stronger liability protection, while an infectious disease expert urged a broadening of the provisions to encourage antibiotic development. Only a handful of senators attended the hearing off and on, as Congress is busily trying to finish its business before the election.
|